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Post-translational protein modification is a prevalent 
means of diversification and regulation in all cells [1]. The 
functional consequences range from immediate effects 
like changes in protein conformation or stability, 
regulation of enzymatic activities to the determination of 
subcellular localization. Tags marking substrates for 
degradation by energy-dependent protease complexes 
exist in pro- and eukaryotes, as exemplified by eukaryotic 
ubiquitination [2, 3] or bacterial co-translational ssrA-
tagging [4]. However, until recently, the use of small-
protein modifiers such as ubiquitin was considered a 
feature exclusive to eukaryotic cells. The discovery of 
pupylation, the covalent modification of protein lysines 
with prokaryotic, ubiquitin-like protein Pup, in 
Mycobacterium tuberculosis (Mtb) and Mycobacterium 
smegmatis [5, 6] and the detection of conjugates between 
small archaeal modifier proteins (SAMPs) and substrate 
lysines in archaea [7, 8] show that prokaryotes also 
employ macromolecular tags. It has been demonstrated 
that modification of target proteins with Pup occurs by 
a chemical pathway distinct from ubiquitination [9] 
(Figure 1). However, like ubiquitination, tagging with Pup 
can render proteins as substrates for proteasomal 
degradation [5, 6, 10]. The existence of a depupylation 
activity in actinobacteria [11, 12] and the fact that some 
members harbor the pupylation gene locus without 
encoding proteasomal subunits suggest that pupylation 
might fulfill a broader role in regulation and cellular 
signaling. The purpose of the pupylation system in 
actinobacteria is still a matter of investigation. In Mtb, 
the Pup-proteasome system (PPS) has been linked to the 
bacterium’s survival strategy inside the host macrophages 
[13, 14].
An ubiquitin-like modification pathway in bacteria 
marks proteins for proteasomal degradation
Actinobacteria form a large and diverse phylum with 
many members living in close association with eukaryotic 
hosts as either pathogens (Mycobacterium spp.) or 
symbionts (nitrogen-fixing or gastrointestinal species) 
[15, 16]. Phylogenetic analysis identified actinobacteria as 
one of the earliest prokaryotic lineages. They are known 
to share traits with eukaryotes [17]. For example, like 
eukaryotes they encode single-chain eukaryotic-like 
fatty-acid synthase (FASI; in addition to the dissociated 
bacterial FASII enzymes) [18], actinomycetes form 
exospores and mycobacteria produce sterols [17]. 
Another eukaryotic-like feature is the existence of 
proteasomes in actinobacteria in addition to the typical 
bacterial-like compartmentalizing protease complexes 
(Clp proteases [19], FtsH [20], Lon [21], but not 
HslUV) [22]. These bacterial proteases are architecturally 
related to the proteasome but of only very distant 
homology [23]. It is still a matter of debate how 
actinobacteria came by their proteasomes. One theory 
proposes horizontal transfer of the corresponding 
proteasomal genes from archaea or eukaryotes [22]. In 
contrast to that, others suggest that the actinobacterial 
proteasome represents an ancestral form, based on their 
hypothesis that eukaryotes and archaea derived from 
actinobacteria [24]. Irrespective of the suggested 
evolutionary scenarios, the fact remains that no bacterial 
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proteasomes were found outside the actinobacterial 
phylum beyond a few sporadic cases in other lineages 
like, for example, nitrospirae [25]. e pupylation 
machinery of nitrospirae, in fact, was speculated to 
originate in Acidimicrobiales by horizontal gene transfer 
[26], which seems to be supported by the recent 
availability of such a genome [27] (Figure 2).
e post-translational modification Pup that recruits 
proteins for degradation by bacterial proteasomes is 
functionally related to the eukaryotic ubiquitin (Ub) tag 
without showing any sequence or structural homology 
(Figure 1). Both proteins are small (below 10 kDa), both 
carry a di-glycine motif either at the very carboxyl 
terminus (Ub) or at the penultimate position (Pup) and 
both are attached to the amino group of lysine side chains 
in target proteins via an isopeptide bond [5, 6, 9]. 
However, the enzymatic pathways for attachment are 
different. Ub is conjugated to substrates in a multi-step 
reaction involving a cascade of three enzymes [2], the Ub 
activating enzyme E1, the Ub conjugating enzyme E2 and 
one of the many Ub-protein ligase E3s that form the 
isopeptide-bond between a substrate lysine and Ub. 
Ligation of Pup to target lysines on the other hand is 
carried out by a single enzyme, the Pup ligase PafA 
(proteasome accessory factor A) [9]. In all mycobacteria 
and many other actinobacteria, preparation of Pup by 
another enzyme (Dop, deamidase of Pup) must, however, 
occur before the actual ligation [9]. is can be likened to 
the processing of the Ub-precursor to reveal the carboxy-
terminal di-glycine motif.
Ub adopts a defined three-dimensional structure in 
solution referred to as the β-grasp fold [28]. In contrast, 
Pup is mostly unstructured in its free, unbound form [29-
31]. It has been noted that the carboxy-terminal half of 
Pup exhibits a pattern of hydrophobic and hydrophilic 
residues typical of coiled-coil formation, and NMR 
analysis revealed signals from weak helix formation in 
that part of the protein [29]. It was therefore suggested 
that Pup interacts with the coiled-coil domains that 
extend from the surface of the proteasomal ATPase ring 
to form a shared coiled-coil. e crystal structure of a 
carboxy-terminal Pup fragment with a fragment of the 
Mpa (mycobacterial proteasomal ATPase) coiled-coil 
domain confirmed this hypothesis, demonstrating that, 
Figure 1. Bacterial pupylation, like eukaryotic ubiquitination, targets proteins for proteasomal degradation. (a,b) Pupylation (a) or 
ubiquitination (b) of a target protein is shown. Both small protein modifiers (red) are attached to a lysine side chain of a substrate protein (grey). 
A random coil model of Pup (red) represents its intrinsically disordered state in solution. In contrast, ubiquitin (Ub) adopts a stable β-grasp fold 
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Figure 2. Occurrence, genomic organization and relatedness of the pupylation gene locus. (a) Phylogenetic analysis of the combined 
Arc, Dop, Pup and PafA amino acid sequences reveals tight clustering of proteasome-harboring members (clusters I and II), whereas members 
without proteasomal genes in the pupylation locus exhibit much greater sequence variation (cluster III). The pupylation enzymes of Leptospirillum 
ferrooxidans, a Nitrospirae exponent, likely originate in a member of the acidimicrobiales, a subclass of the actinobacteria. (b) Genomic context of 
the pupylation-relevant enzymes. The genomes are listed counter clockwise as they appear in (a). The enzymatic order in the genome is rigidly 
conserved through all pupylation-competent organisms, although some species exist (as Saccharopolyspora erythraea or Salinispora tropica) with 
duplicated parts of the system. L. ferrooxidans contains two copies of the entire system (L1, L2), which are identical in terms of genetic context, but 
very different in their sequence (Pup in L2 even lacks the terminal GGE). The phylogenetic tree was calculated using PhyML [61] and displayed with 












Mpa / Arc Dop Pup PrcB PrcA
space
Paf A



































































Barandun et al. BMC Biology 2012, 10:95 
http://www.biomedcentral.com/1741-7007/10/95
Page 3 of 9
indeed, Pup can adopt such a structure when associated 
with binding partners [32]. Engagement of a pupylated 
substrate into the proteasome occurs by means of the 
unstructured amino-terminal portion of Pup that is first 
threaded into the Mpa central pore and then translocated 
into the proteasomal degradation chamber [10, 33].
Pupylation gene locus and its spread in bacterial 
species
In mycobacteria and most other actinobacteria, the 
prokaryotic ubiquitin-like protein Pup is encoded 
directly upstream of the 20S proteasomal subunit genes 
(prcB, prcA) (Figure 2b). The pup gene is usually preceded 
by the dop gene, while the Pup ligase gene, pafA, is 
located downstream of the proteasomal subunit genes, in 
some cases separated by multiple functionally unrelated 
open reading frames. The proteasomal ATPase gene 
(referred to as mpa in mycobacteria or as arc in other 
actinobacteria) is also found in close proximity, located in 
most cases in a separate operon upstream of dop.
All pup genes encode small proteins ranging from 60 to 
70 residues in length. As mentioned, despite the 
functional analogy, Pup does not exhibit any sequence 
homology to ubiquitin except for the di-glycine motif 
near the carboxyl terminus. Interestingly, Pup sequences 
end in Gly-Gly-Gln (PupQ) or Gly-Gly-Glu (PupE) 
depending on the bacterial species, with some organisms 
even featuring two pup genes, one for PupQ and one for 
PupE. All mycobacterial Pup sequences, however, 
invariantly feature the GGQ terminus.
Some actinobacteria – for example, corynebacteria – 
possess the pupylation genes but lack the proteasomal 
subunit genes (Figure 2b). In those genomes, pup directly 
precedes the Pup ligase gene pafA. Interestingly, these 
genomes nevertheless maintain the proteasomal ATPase 
gene. Furthermore, the ATPases from organisms without 
proteasome subunit genes do not harbor the carboxy-
terminal proteasome-interaction motif [34]. This implies 
that, at least in these bacteria, the proteasomal ATPase 
plays a different role in the pupylation system than 
targeting pupylated substrates for proteasomal 
degradation.
Indeed, subjecting the pupylation-characteristic 
enzymes to phylogenetic analysis (without including 
proteasomal subunits) reveals a clustering different from 
the common phylogenetic relationships of the respective 
bacteria (Figure 2a). For example, the pupylation 
machinery of proteasome-harboring Corynebacterineae 
forms a tight cluster closely related to the enzymes of 
many representatives of related clades. However, they are 
only weakly linked to the proteins of the genus 
Corynebacterium, although this genus belongs to the 
same bacterial suborder. Interestingly, the enzymes of 
proteasome-lacking organisms exhibit more sequence 
variation, only matched by Nitrospirae exponents. These 
features could indicate directional evolution after a 
dramatic genomic change, as, for example, the loss of the 
proteasome or the horizontal gain of the entire 
pupylation system.
The enzymes of the pupylation pathway
During pupylation an isopeptide bond is formed between 
the small protein tag Pup and a lysine residue of the 
target protein [5, 6, 9] (Figure 1). In mycobacteria, this 
involves the sequential action of two homologous 
enzymes, the deamidase Dop (deamidase of Pup) and the 
Pup ligase PafA (proteasome-accessory factor A) [9] 
(Figure 3). First, Pup is rendered coupling-competent by 
deamidation of its carboxy-terminal glutamine to 
glutamate through the action of Dop (Figure 4a, reaction 
scheme). In the second step, the enzyme PafA catalyzes 
the formation of an isopeptide bond between Pup’s 
carboxy-terminal glutamate and the e-amino group of a 
lysine residue on the substrate protein (Figure 4b, 
reaction scheme). Deletion strains of Mtb or 
M. smegmatis lacking the pafA or the dop gene are unable 
to produce pupylated target proteins [5, 35, 36], 
demonstrating that only one ligase and deamidase are 
responsible for the pupylation pathway. NMR analysis 
revealed that the side chain carboxylate of Pup’s carboxy-
terminal glutamate forms the linkage to the substrate-
lysine [37]. This is different from the linkage of ubiquitin, 
which occurs via the terminal carboxylate of the end-
standing glycine. The entire pupylation pathway has been 
reconstituted in vitro for Mtb and Corynebacterium 
glutamicum [9, 12, 38].
A key feature of regulatory post-translational 
modification mechanisms is their reversibility [1]. In 
eukaryotes ubiquitination is reversed by the action of 
deubiquitinases breaking the isopeptide linkage between 
ubiquitin and target lysines [39-41]. It was shown that 
Dop, the enzyme responsible for rendering Pup ligation-
competent, also acts as a depupylase, removing Pup from 
substrates by specific cleavage of the isopeptide bond 
between Pup and the substrate [11, 12] (Figure 4a, 
reaction scheme). This explains why some actinobacteria 
encoding Pup with a carboxy-terminal glutamate (like 
C.  glutamicum), bypassing the need for deamidation to 
become coupling-competent, still maintain a dop gene 
(Figure 2b). Interestingly, the proteasomal ATPase Mpa 
enhances depupylation in vitro [12], likely by making the 
isopeptide bond to target proteins more accessible. This 
might be one reason the ATPase gene is maintained in 
actinobacteria that possess the puplyation enzymes in 
absence of the proteasome core particle (Figure 2b). In 
summary, this suggests a role for Pup that is independent 
of degradation – for example, as a regulatory tag 
analogous to mono-ubiquitination.
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Structure and mechanism of the enzymes involved 
in pupylation and depupylation
e Pup ligase PafA and the deamidase/depupylase Dop 
are close structural homologs [38] and are related to the 
carboxylate-amine ligase superfamily [25] (Figure 4). 
Bioinformatic analysis of non-ribosomal bacterial 
amidoligases suggests that Pup-ligase PafA is an 
evolutionary derivative of glutamine synthetases [42]. In 
the same study, it was also proposed that the Pup tag 
itself might have evolved from ribosomally synthesized 
and later cyclized bioactive peptides produced, for 
example, as defensins (like marinostatin). e authors 
reason that, like these peptide metabolites, Pup is 
small and disordered. Instead of cyclization, however, 
ligation in the case of Pup occurs as conjugation to other 
proteins.
Both Dop and PafA are globular in shape and consist of 
two tightly interacting domains, a large amino-terminal 
domain of about 400 residues and a small carboxy-
terminal domain of about 70 residues [38] (Figure 4). e 
amino-terminal domain is homologous to the 
carboxylate-amine ligase family [25]. It consists of a 
curved, six-stranded β-sheet that packs against a cluster 
of helices. e active site is located on the concave side of 
the β-sheet with ATP bound in a deep pocket at one end 
of the sheet. A defined, well-conserved groove leads into 
the active site at the opposite end and has been proposed 
as the Pup-binding groove [38]. In PafA, this would place 
the carboxy-terminal glutamate of Pup directly into the 
active site at the position where glutamate is found in the 
related glutamine synthetase enzymes. e open access 
to the active site on the shallow β-sheet cradle allows 
accommodation of a diverse range of substrate proteins 
of varying sizes and oligomeric states.
Despite featuring highly homologous folds, Dop and 
PafA catalyze separate reactions with opposing activities 
Figure 3. The pupylation/depupylation cycle in mycobacteria. Dop (green) renders PupQ ligation-competent by deamidating the carboxy-
terminal glutamine to glutamate. The Pup ligase PafA (blue) then performs the isopeptide-bond formation between the γ-carboxylate of Pup’s 
carboxy-terminal glutamate and the ε-amino group of a substrate (grey). Dop also carries out the specific cleavage of the isopeptide-bond in a 
pupylated substrate, depupylating the tagged substrate protein. Pup (red) has been placed in the proposed Pup-binding groove of Dop or PafA 
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[9, 11, 12] (Figure 3). e Pup ligase PafA forms the 
isopeptide bond between the protein lysyl moiety and 
Pup’s carboxy-terminal glutamate [9], while Dop removes 
the protein lysyl moiety (or ammonia) from the Pup 
carboxy-terminal side chain [9, 11, 12]. Formation of the 
isopeptide bond by PafA requires turnover of ATP to 
ADP [9]. It has been demonstrated that the reaction 
proceeds through a γ-glutamyl-phosphate mixed 
anhydride intermediate that is formed on the carboxy-
terminal glutamate of Pup to activate it for nucleophilic 
attack by the lysine side chain [43]. During deamidation/
depupylation, activation is not needed; thus, no ATP 
turnover takes place [9, 12]. In both reactions, a 
nucleophilic attack must occur on the carbonyl-carbon of 
Pup’s carboxy-terminal glutamine/glutamate side chain 
by either water, in the case of Dop, or the ε-amino group 
of lysine, in the case of PafA. A loop between two of the 
strands in the β-sheet cradle is ideally located to provide 
catalytic assistance and contains a conserved aspartate 
that has been proposed as the catalytic base that activates 
the nucleophile (water or lysine side chain) [38]. A 
mechanistic study on Dop also identified this aspartate as 
a crucial catalytic residue and proposes that it might even 
act as a direct nucleophile, forming a covalent 
intermediate with Pup [44].
Role of the Pup-proteasome system in 
actinobacteria and for pathogenicity of Mtb
Actinobacteria carry the PPS in addition to a subset of 
the usual bacterial energy-dependent proteases (Clp 
proteases, the membrane-associated FtsH, Lon) [45]. e 
ATP-dependent protease profiles differ between the 
individual members [45]. Proteasome subunit-bearing 
bacteria generally do not have HslUV, another 
compartmentalizing protease complex, but they may 
code for Lon protease (leptospirilli present an exception 
and carry both). For example, Mtb lacks both HslUV and 
Lon protease, while M. smegmatis retains a lon gene. 
Disruption of 20S proteasome subunit genes in M. 
smegmatis as well as in Streptomyces coelicolor and 
lividans resulted in mutant strains with the same growth 
behavior in standard liquid aerobic culture as their parent 
strains [46-48]. Even in Mtb, where both HslUV and Lon 
are lacking, removal of the 20S subunits has only minor 
effects on growth under standard culture conditions [13]. 
Likewise, disrupting other genes of the pupylation gene 
locus does not result in a significant change in growth 
phenotypes in standard liquid culture [14, 48, 49]. is 
suggests that the PPS might provide an advantage under 
specific environmental conditions encountered by the 
bacteria or during the switch to a different state in their 
Figure 4. Dop and PafA are close structural homologs but catalyze distinct reactions. (a,b) The structures of Dop (a) and PafA (b) are shown 
in cartoon representation with ATP/ADP displayed in stick format. The catalyzed reactions are shown below the corresponding enzyme. For 
deamidation, R denotes a hydrogen; for depupylation or ligation, R denotes the protein lysyl moiety. Pup (dotted red line) is represented as binding 
in the putative Pup-binding groove with its carboxy-terminal glutamate (red, sticks) placed in the active site according to the position of glutamate 
in glutamyl-cysteine ligase (PDB: 2gwd). In PafA, Pup is displayed in its activated form corresponding to the phosphorylated intermediate shown in 
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life cycle. One organism facing particular challenges 
during its life cycle is the human pathogen Mtb.
The cellular machinery of Mtb is optimized to persist in 
one of the most inhospitable niches in humans, the 
macrophage [50]. While inside the host, Mtb faces 
multiple chemical stresses, such as a drop in pH, reactive 
oxygen species and increased toxic ion concentration [51, 
52]. However, a primary killing mechanism employed by 
infected macrophages is the production of highly reactive 
nitrogen intermediates (RNIs) produced by the 
interferon-g-inducible nitric oxide synthase (iNOS, 
NOS2) [53]. Mtb lacking the 20S subunits is highly 
susceptible to nitrosative stress in vitro and silencing of 
the Mtb 20S proteasome after inhalation-infection of 
mice leads to lung bacterial counts reduced by two or 
three orders of magnitude [13]. A transposon 
mutagenesis screen aimed at finding targets that 
contribute to making Mtb resistant to nitrosative stress 
identified mutants in the PPS gene locus in the mpa and 
pafA genes [14]. This points to a role of the PPS in 
helping Mtb cope with RNIs, perhaps by clearing 
damaged proteins. However, the role of the PPS must go 
beyond mere defense against nitrosative stress, because 
interferon-g-deficient mice that are unable to induce 
nitrosative stress still show significantly increased 
survival when infected with a proteasome-depleted Mtb 
strain versus wild-type Mtb [13]. Furthermore, proteomic 
studies on standard in vitro cultures of Mtb and M. 
smegmatis identified around 700 pupylation targets 
associated with a wide range of cellular functions, 
including a large number from intermediary or lipid 
metabolism [54-56]. This suggests that the effect of the 
PPS on Mtb survival in the host could be multicausal and 
might be related to more than one set of substrates. 
Investigation of transcriptional changes in Mtb with a 
defective PPS identified changes in the genes of two 
regulons, the zinc-uptake regulon and a copper-
responsive regulon [57]. The changes indicated that the 
PPS knockouts have lower intracellular levels of zinc and 
copper, though it is unclear how the PPS affects these 
levels. Furthermore, no direct link to pathogenicity of 
Mtb could be made.
Although a lot has been learned about pupylation, its 
mechanism, in vivo effects and spectrum of substrates, 
the ultimate question of what role the PPS plays for Mtb 
pathogenicity remains yet unanswered.
Outlook
The discovery of pupylation established that bacteria use 
macromolecular tagging in their post-translational 
modification repertoire. The functional analogies to 
ubiquitination, yet separate evolutionary origin and 
distinct modification pathway, have sparked great interest 
in this system. The fact that one of the deadliest bacterial 
pathogens known to mankind, Mycobacterium 
tuberculosis (Mtb), makes use of the pupylation pathway 
to help overcome the immune defense of its host, adds 
the compelling element of biomedical relevance to an 
exciting biological system.
But this is also where several questions still await 
answering. By what mechanism does pupylation impact 
the virulence of Mtb? And why do non-pathogenic 
members of this phylum maintain this system in their 
genome? It is doubtful whether these answers can be 
obtained by investigation of lab cultures grown under 
standard conditions, where the PPS is verifiably not 
required. Rather, it is now crucial to investigate this 
question under conditions where pupylation contributes 
to survival. In this context, it will be critical to obtain 
information about the nature of the pupylome from Mtb 
inside activated macrophages. This might shed light on 
which pupylation substrates or groups of substrates 
provide the decisive advantage. Another open question is 
the role of pupylation in the context of proteasomal 
degradation. To what degree is pupylation truly a 
degradation tag and to what degree does it act as a 
regulatory tag? Answers to these questions might come 
from investigating actinobacterial members that have 
lost the proteasomal genes and hence the degradative 
branch of pupylation. A somewhat puzzling observation 
has been the existence of just one ligase for attaching Pup 
to a large range of target proteins. How are substrates 
selected for pupylation? It remains to be seen whether 
additional cellular factors impose some selectivity and 
regulation on the system.
With the insights already gained about pupylation in 
mycobacteria over the past few years an excellent 
foundation has been laid on which to build future 
experimental approaches. One important route is 
certainly also the pursuit of the PPS as a drug target to 
combat, in particular, the emerging multi-drug resistant 
Mtb strains [58-60].
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